BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3495168)

  • 21. Susceptibility of Clostridium difficile to metronidazole, its bioactive metabolites and tinidazole.
    Bannatyne R; Jackowski J
    Eur J Clin Microbiol; 1987 Aug; 6(4):505-6. PubMed ID: 3665909
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative activity of metronidazole and tinidazole against Clostridium difficile and Peptostreptococcus anaerobius.
    Jokipii AM; Jokipii L
    Antimicrob Agents Chemother; 1987 Feb; 31(2):183-6. PubMed ID: 3566248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardized methods.
    Wust J
    Antimicrob Agents Chemother; 1977 Apr; 11(4):631-7. PubMed ID: 856015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of Gardnerella vaginalis to thiamphenicol: clinical experience with nonspecific vaginitis.
    Hubrechts JM; Vanhoof RL; Daems A; Butzler JP
    Sex Transm Dis; 1984; 11(4 Suppl):456-9. PubMed ID: 6335301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of non-specific vaginitis with a single dose of tinidazole.
    van der Meijden WI
    Scand J Infect Dis Suppl; 1983; 40():85-9. PubMed ID: 6364333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole.
    Schwebke JR; Barrientes FJ
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4209-10. PubMed ID: 17000740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sensitivity of Gardnerella vaginalis to antibiotics. Study of 40 strains isolated at the Purpan University Hospital Center of Toulouse].
    Lefevre JC; Prere MF; Lareng MB
    Pathol Biol (Paris); 1983 Jun; 31(6):533-5. PubMed ID: 6348664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial effects of niridazole on Gardnerella vaginalis.
    Bannatyne RM; Jackowski J
    Infection; 1987; 15(2):128. PubMed ID: 3496279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis.
    Narcisi EM; Secor WE
    Antimicrob Agents Chemother; 1996 May; 40(5):1121-5. PubMed ID: 8723451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.
    Lamp KC; Freeman CD; Klutman NE; Lacy MK
    Clin Pharmacokinet; 1999 May; 36(5):353-73. PubMed ID: 10384859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro interactions between metronidazole or tinidazole and ampicillin, doxycycline and co-trimoxazole on the effect against anaerobic bacteria.
    Bergan T; Fotland MH
    Scand J Gastroenterol Suppl; 1984; 91():95-101. PubMed ID: 6610923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anaerobic effect of tinidazol compared with metronidazol, ornidazol, cefoxitin and lamoxactam].
    Werner H; Kuchenbecker K; Hammann R
    Immun Infekt; 1983 Jun; 11(4):143-7. PubMed ID: 6676177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of intrinsically metronidazole-resistant clades of Gardnerella vaginalis.
    Schuyler JA; Mordechai E; Adelson ME; Sobel JD; Gygax SE; Hilbert DW
    Diagn Microbiol Infect Dis; 2016 Jan; 84(1):1-3. PubMed ID: 26514076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro susceptibility of Giardia lamblia trophozoites to metronidazole and tinidazole.
    Jokipii L; Jokipii AM
    J Infect Dis; 1980 Mar; 141(3):317-25. PubMed ID: 7365281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro and in-vivo activity of metronidazole against Gardnerella vaginalis, Bacteroides spp. and Mobiluncus spp. in bacterial vaginosis.
    Jones BM; Geary I; Alawattegama AB; Kinghorn GR; Duerden BI
    J Antimicrob Chemother; 1985 Aug; 16(2):189-97. PubMed ID: 3905748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metronidazole for non-specific vaginitis.
    Bardi M; Manenti G; Mattioni D; Lasala L
    Lancet; 1980 May; 1(8176):1029. PubMed ID: 6103353
    [No Abstract]   [Full Text] [Related]  

  • 37. Bacteriocin susceptibility of Gardnerella vaginalis and its relationship to biotype, genotype, and metronidazole susceptibility.
    Simoes JA; Aroutcheva A; Heimler I; Shott S; Faro S
    Am J Obstet Gynecol; 2001 Nov; 185(5):1186-90. PubMed ID: 11717655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antibacterial and bactericidal activity of tinidazole against anaerobic bacteria comparing with metronidazole (author's transl)].
    Ninomiya K; Kobata S; Imamura H; Mochizuki I; Watanabe K
    Jpn J Antibiot; 1976 Mar; 29(3):325-31. PubMed ID: 1271586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibacterial activity and pharmacokinetics of nitroimidazoles. A review.
    Bergan T
    Scand J Infect Dis Suppl; 1985; 46():64-71. PubMed ID: 3865352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ["In vitro" susceptibility of some aerobic and anaerobic bacteria to three 5-nitro-imidazole derivatives: metronidazole, ornidazole and tinidazole (author's transl)].
    Dublanchet A; Durieux R
    Ann Microbiol (Paris); 1980; 131(1):45-59. PubMed ID: 7362180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.